BCAX
Bicara Therapeutics Inc. Common Stock
NASDAQ: BCAX · HEALTHCARE · BIOTECHNOLOGY
$21.28
-2.92% today
Updated 2026-04-29
Market cap
$1.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$8 – $24
Volume
0.6M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
3.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$30.50
+43.33%
12-Month target
$18.67
-12.27%
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy8 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.39 — safe zone
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-24.12M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-37.84M | $-51.98M | $-68.00M | $-137.95M | $-37.39M |
| EPS | — | — | — | — | $-2.52 |
| Free cash flow | $-32.27M | $-46.21M | $-74.82M | $-107.11M | $-24.12M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Bicara Therapeutics Inc. Common Stock trades at $21.28. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.39, it sits in the safe zone.
Frequently asked questions
What is Bicara Therapeutics Inc. Common Stock's stock price?
Bicara Therapeutics Inc. Common Stock (BCAX) trades at $21.28.
Is Bicara Therapeutics Inc. Common Stock overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Bicara Therapeutics Inc. Common Stock (BCAX)?
The analyst target price is $30.50, representing +43.3% upside from the current price of $21.28.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
3.39 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-30.90%
Beta—
50D MA$19.82
200D MA$16.11
Shares out0.07B
Float0.04B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—